About
Cell Therapy, Antibodies, Small Molecules
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalGene Therapy, RNA & Peptide TherapyStem Cell & Cellular TherapyAntibodySan Diego & Southern California
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
267
By Phase
PHASE1: 1NA: 6
By Status
COMPLETED: 6WITHDRAWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05341947Collaborator
Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
PHASE1Withdrawn
Started: Jun 30, 2026 · Completed: Dec 31, 2027
NCT05552378Lead Sponsor
Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms
NACompleted
40 participants
Started: Feb 20, 2023 · Completed: Apr 5, 2023
NCT05732337Lead Sponsor
Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.
NACompleted
28 participants
Started: Jan 30, 2023 · Completed: Jul 5, 2023
NCT05560841Lead Sponsor
Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis
NACompleted
50 participants
Started: Jul 28, 2022 · Completed: Apr 10, 2023
NCT05211921Lead Sponsor
Single Arm Study of Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis
NACompleted
50 participants
Started: Dec 7, 2021 · Completed: May 11, 2022
Locations (1)
Headquarters
Los Angeles, CA, United States
Map
Loading map...